134 related articles for article (PubMed ID: 33208626)
1. Laparoscopic Port-Site Metastasis From Prostate Cancer on 18F-Fluciclovine PET/CT.
Tran G; Parrinello D; Dalal I
Clin Nucl Med; 2021 May; 46(5):e279-e281. PubMed ID: 33208626
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic performance of 18F-fluciclovine PET/CT for regional lymph node metastases in patients with primary prostate cancer: a multicenter phase II clinical trial.
Suzuki H; Jinnouchi S; Kaji Y; Kishida T; Kinoshita H; Yamaguchi S; Tobe T; Okamura T; Kawakita M; Furukawa J; Otaka A; Kakehi Y
Jpn J Clin Oncol; 2019 Sep; 49(9):803-811. PubMed ID: 31095314
[TBL] [Abstract][Full Text] [Related]
3. Isolated Intravascular Prostate Carcinoma Recurrence Confirmed With 18F-Fluciclovine PET/CT and MRI.
Agely A; Sharma A; Parent EE; Nawaz A; Jain MK
Clin Nucl Med; 2020 Jun; 45(6):442-443. PubMed ID: 32332299
[TBL] [Abstract][Full Text] [Related]
4. [
Alemozaffar M; Akintayo AA; Abiodun-Ojo OA; Patil D; Saeed F; Huang Y; Osunkoya AO; Goodman MM; Sanda M; Schuster DM
J Urol; 2020 Oct; 204(4):734-740. PubMed ID: 32347780
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic performance of F-18 fluciclovine PET/CT in post-radical prostatectomy prostate cancer patients with rising prostate-specific antigen level ≤0.5 ng/mL.
Teyateeti A; Khan B; Teyateeti A; Chen B; Bridhikitti J; Pan T; Peng W; Macapinlac HA; Lu Y
Nucl Med Commun; 2020 Sep; 41(9):906-915. PubMed ID: 32796479
[TBL] [Abstract][Full Text] [Related]
6.
Calais J; Ceci F; Eiber M; Hope TA; Hofman MS; Rischpler C; Bach-Gansmo T; Nanni C; Savir-Baruch B; Elashoff D; Grogan T; Dahlbom M; Slavik R; Gartmann J; Nguyen K; Lok V; Jadvar H; Kishan AU; Rettig MB; Reiter RE; Fendler WP; Czernin J
Lancet Oncol; 2019 Sep; 20(9):1286-1294. PubMed ID: 31375469
[TBL] [Abstract][Full Text] [Related]
7. Small Lymph Node Metastasis Detected by 68Ga-Prostate-Specific Membrane Antigen But Not 18F-Fluciclovine PET/CT in Low-Prostate-Specific Antigen Biochemical Recurrence of Prostate Cancer.
Chaussé G; Abikhzer G; Probst S
Clin Nucl Med; 2018 Apr; 43(4):250-251. PubMed ID: 29465489
[TBL] [Abstract][Full Text] [Related]
8. Prostate cancer recurrence in patients with negative or equivocal conventional imaging: A role for
Kim EH; Siegel BA; Teoh EJ; Andriole GL;
Urol Oncol; 2021 Jun; 39(6):365.e9-365.e16. PubMed ID: 33160848
[TBL] [Abstract][Full Text] [Related]
9. 18F-Fluciclovine-Avid Pulmonary Hamartoma.
Baldeosingh SC; Rowe SP; Greco SC; Paller CJ; Goel R
Clin Nucl Med; 2021 Nov; 46(11):919-921. PubMed ID: 34582137
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic accuracy of 18F-fluciclovine PET/CT in primary lymph node staging of prostate cancer.
Hoekstra RJ; Beulens A; Vrijhof EHJEJ; Wyndaele DNJ; Roef M; Brouwer LJM; Somford DM; Sedelaar M; van Basten JA
Nucl Med Commun; 2021 May; 42(5):476-481. PubMed ID: 33323869
[TBL] [Abstract][Full Text] [Related]
11. Prostate Cancer Liver Metastases Presenting as Relatively Photopenic Lesions on 18F-Fluciclovine PET/CT.
Baiomy A; Martiniova L; Efstathiou E; Schuster DM; Ravizzini G
Clin Nucl Med; 2021 Apr; 46(4):e240-e241. PubMed ID: 33208612
[TBL] [Abstract][Full Text] [Related]
12. 18F-Fluciclovine Uptake in a Ureterocele.
Bitar R; Szklaruk J; Martiniova L; Zurita AJ; Chery LJ; Ravizzini G
Clin Nucl Med; 2021 Jan; 46(1):e3-e5. PubMed ID: 32956112
[TBL] [Abstract][Full Text] [Related]
13. Superscan 18F-Fluciclovine PET/CT of PSA-Negative Prostate Cancer Bone Metastases.
Chen B; Macapinlac HA; Lu Y
Clin Nucl Med; 2019 Apr; 44(4):337-338. PubMed ID: 30688749
[TBL] [Abstract][Full Text] [Related]
14. The Clinical Utility of
Nakamoto R; Harrison C; Song H; Guja KE; Hatami N; Nguyen J; Moradi F; Franc BL; Aparici CM; Davidzon G; Iagaru A
Mol Imaging Biol; 2021 Aug; 23(4):614-623. PubMed ID: 33469884
[TBL] [Abstract][Full Text] [Related]
15. Is There Any Role for 18F-Fluciclovine PET/CT in the Presence of Undetectable PSA in Prostate Cancer Patients After Definitive Treatment?
Teyateeti A; Teyateeti A; Macapinlac HA; Lu Y
Clin Nucl Med; 2020 Sep; 45(9):672-678. PubMed ID: 32604105
[TBL] [Abstract][Full Text] [Related]
16. Incidental 18F-Fluciclovine Uptake in a Desmoid Tumor Detected in a Patient Undergoing PET/CT Imaging for Prostate Cancer.
Baiomy A; Jensen CT; Ward JF; Chasen BA; Ravizzini GC
Clin Nucl Med; 2021 Apr; 46(4):355-357. PubMed ID: 33323736
[TBL] [Abstract][Full Text] [Related]
17. Comparison of
Calais J; Fendler WP; Herrmann K; Eiber M; Ceci F
J Nucl Med; 2018 May; 59(5):789-794. PubMed ID: 29242404
[TBL] [Abstract][Full Text] [Related]
18. Recurrent Malignant Melanoma Detected on 18F-Fluciclovine PET/CT Imaging for Prostate Cancer.
Teoh EJ; Tsakok MT; Bradley KM; Hyde K; Subesinghe M; Gleeson FV
Clin Nucl Med; 2017 Oct; 42(10):803-804. PubMed ID: 28806256
[TBL] [Abstract][Full Text] [Related]
19. Initial Institutional Experience with 18F-Fluciclovine PET-CT in Biochemical Recurrence of Prostate Cancer.
Farkas AB; Green ED; Thaggard AL; Vijayakumar V; Henegan JC; Lirette ST; Nittala MR; Vijayakumar S
South Med J; 2021 Nov; 114(11):703-707. PubMed ID: 34729614
[TBL] [Abstract][Full Text] [Related]
20. Utility of
Wang Y; Chow DZ; Ebert E; Tajmir S; Scott JA; Palmer EL
AJR Am J Roentgenol; 2020 Oct; 215(4):997-1001. PubMed ID: 32569513
[No Abstract] [Full Text] [Related]
[Next] [New Search]
